Dr. Shreema Sawlani, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-1000 Fax: 262-434-3702 |
Michael C Schmitt, Anesthesiology Medicare: Medicare Enrolled Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-1000 Fax: 262-434-5050 |
Charles R Hollman, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-1000 |
Travis M Hecker, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-5000 Fax: 262-434-5350 |
Susan M Smith, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-1000 |
Dr. Angelo Louis Lambropoulos, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-1000 |
Dean M Weich Jr., DO Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-1000 Fax: 262-434-5050 |
News Archive
Returning to school can be a stressful time, especially for teens. Many teens face stress from the new demands of school, puberty, changing relationships, family responsibilities and safety issues in their neighborhoods. However, teen stress is not always recognized by adults.
A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control diabetes, as well or even better than the best medical treatment available today. This is the first study of its kind open to patients who are overweight or mildly obese.
The evidence has been clear for a long time now regarding the future of those twin financial train wrecks known as Social Security and Medicare. We have known for decades that without significant reform both are on a path toward insolvency.
This year, the U.S. Food and Drug Administration is expected to approve the first malaria drug to contain artemisinin, a wormwood derivative from China that has proven effective for malaria in Africa and Asia.
› Verified 1 days ago